Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PANCREAS”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00097773
What this trial is testing

Comparison of Two Treatment Regimens to Reduce PA Infection in Children With Cystic Fibrosis

Who this might be right for
Cystic FibrosisPulmonary Disease, Chronic Obstructive
Seattle Children's Hospital 304
Early research (Phase 1)Study completedNCT03029455
What this trial is testing

Evaluate Safety and Pharmacokinetics of VX-659 in Healthy Subjects and in Adults With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 163
Early research (Phase 1)WithdrawnNCT01057355
What this trial is testing

Endoscopic Ethanol Ablation of Communicating Pancreatic Cystic Neoplasms

Who this might be right for
Neoplasms, Cystic, Mucinous, and SerousPancreatic NeoplasmsUltrasonography, Interventional
Mayo Clinic
Testing effectiveness (Phase 2)Looking for participantsNCT07012772
What this trial is testing

COMBO Endoscopy Oropharyngeal Airway in Sedated Endoscopic Retrograde Cholangiopancreatography for Patients

Who this might be right for
Choledocholithiasis With Cholecystitis With ObstructionObstructive JaundicePancreatitis+1 more
Zhejiang University 50
Testing effectiveness (Phase 2)UnknownNCT02863367
What this trial is testing

A One-Arm Exploratory Clinical Trial of Apatinib Plus Gemcitabine in Patients With Advanced Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Cancer
Tianjin Medical University Cancer Institute and Hospital 30
Testing effectiveness (Phase 2)UnknownNCT04151277
What this trial is testing

PRIMUS 001: A Study Looking at Two Different Chemotherapy Regimens in Patients With Metastatic Pancreatic Cancer

Who this might be right for
Neoplasms Pancreatic
Judith Dixon-Hughes 500
Testing effectiveness (Phase 2)UnknownNCT04324307
What this trial is testing

Study of Immunotherapy Combined With Chemotherapy in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Locally Advanced and Metastatic Pancreatic Cancer
Changhai Hospital 60
Not applicableLooking for participantsNCT05724992
What this trial is testing

Familial Pancreatic Cancer PROPHilation Program in Italy

Who this might be right for
Candidates for Hereditary Pancreatic Cancer Testing
Associazione Italiana per lo Studio del Pancreas 3,000
Not applicableStudy completedNCT04902144
What this trial is testing

Clinical Outcomes for Offering Genetic Testing in a Tiered Approach

Who this might be right for
Breast CarcinomaColon CarcinomaMalignant Solid Neoplasm+3 more
Fred Hutchinson Cancer Center 6
Large-scale testing (Phase 3)Study completedNCT00918957
What this trial is testing

Tobramycin Inhalation Powder From a Modified Manufacturing Process Versus Placebo

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals 62
Not applicableStudy completedNCT06606457
What this trial is testing

PACE CF, a 3-session Mind-body Pain Management Program for Adults With Cystic Fibrosis

Who this might be right for
Cystic Fibrosis (CF)Pain Management
Massachusetts General Hospital 20
Not applicableWithdrawnNCT06691919
What this trial is testing

Surgical vs Endoscopic Resection of Walled Off Pancreatic Necrosis Using the Powered Endoscopic Debridement System

Who this might be right for
Pancreatic NecrosisPancreatitis
Stanford University
Large-scale testing (Phase 3)Study completedNCT01082367
What this trial is testing

Randomized, Controlled Study of CF Patients Between 3 Months and Less Than 7 Years

Who this might be right for
Treatment of Early Pulmonary Infections With P. Aeruginosa in Cystic Fibrosis Patients
Novartis Pharmaceuticals 50
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06866977
What this trial is testing

A Single-arm, Open-label Clinical Study to Evaluate the Efficacy and Safety of VRT106 in Combination With Chemotherapy for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Xiangya Hospital of Central South University 10
Large-scale testing (Phase 3)Study completedNCT01614457
What this trial is testing

Study of Ivacaftor in Subjects With Cystic Fibrosis (CF) Who Have the R117H-CF Transmembrane Conductance Regulator (CFTR) Mutation (KONDUCT)

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 70
Not applicableUnknownNCT04900012
What this trial is testing

Prospective Snapshot Audit of Distal Pancreatectomy in Spain

Who this might be right for
Surgery--ComplicationsPancreas DiseasePancreatic Fistula
Hospital General Universitario de Alicante 500
Not applicableStudy completedNCT00489671
What this trial is testing

Urine Cadmium Levels in Predicting Pancreatic Cancer Risk in Patients With Chronic Pancreatitis

Who this might be right for
Pancreatic CancerPrecancerous Condition
Wake Forest University Health Sciences 32
Not applicableLooking for participantsNCT06803771
What this trial is testing

Surveillance of Pancreatic Health After Diabetes Diagnosis

Who this might be right for
Diabetes MellitusPancreatic Cancer, Adult
University Hospital Southampton NHS Foundation Trust 15,000
Not applicableStudy completedNCT01460836
What this trial is testing

Indirect Comparison of Tobramycin Solution for Inhalation Versus Aztreonam Lysine for Inhalation in the Treatment of Cystic Fibrosis

Who this might be right for
Cystic Fibrosis
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07469956
What this trial is testing

Surufatinib Plus mFOLFIRINOX and PD-1 Inhibitor as the Neoadjuvant Therapy for High-risk or Borderline Resectable Pancreatic Cancer

Who this might be right for
Pancreatic Cancer Resectable
Sun Yat-sen University 30
Next Page